Home › Funds › Future Fund LLC › HALO

Future Fund LLC position in HALO

HALOZYME THERAPEUTICS INC · Health Care

Future Fund LLC reported holding 79,799 shares of HALO (HALOZYME THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$8.8M, representing 2.66% of its reported portfolio and ranking #3 among its reported holdings. Future Fund LLC has disclosed HALO holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)79.80K sh
Reported value held$8.81M
Portfolio Weight2.66%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Future Fund LLC's HALO position evolved

Future Fund LLC first disclosed a stake in HALO in Q3 2023 at 8,566 shares (US$327K). The position peaked in Q2 2026 at 142,007 shares, worth US$11.1M. Across 13 filings, Future Fund LLC increased the stake 9 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 79,799 shares valued at US$8.8M — a reduction of -62,208 shares quarter over quarter.. Notable position changes include a 71% increase in Q1 2024 (shares rose 29% over the following quarter), a 196% increase in Q2 2024 (shares rose 9% over the following quarter), a 92% increase in Q1 2025 (shares fell 18% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 8.57K $327.22K New
Q4 2023 7.17K $264.86K Reduce
Q1 2024 12.28K $499.35K Add
Q2 2024 36.30K $1.89M Add
Q3 2024 11.10K $634.14K Reduce
Q4 2024 17.60K $841.26K Add
Q1 2025 33.82K $2.16M Add
Q2 2025 55.69K $2.90M Add
Q3 2025 62.45K $4.58M Add
Q4 2025 83.03K $5.59M Add
Q1 2026 95.12K $6.15M Add
Q2 2026 142.01K $11.11M Add
Q3 2026 79.80K $8.81M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About HALO and 13F data

HALO (HALOZYME THERAPEUTICS INC) is a Health Care company. 45 other funds we track also report a position in HALO — the largest reported positions include CONGRESS ASSET MANAGEMENT CO (US$251.9M), SNYDER CAPITAL MANAGEMENT L P (US$187.5M), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (US$178.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding HALO

All HALO fund holders →

FAQ

How long has Future Fund LLC held HALO?

Future Fund LLC has disclosed HALO holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Future Fund LLC's current position in HALO?

As of Q3 2026, Future Fund LLC holds 79.80K shares of HALO (HALOZYME THERAPEUTICS INC), valued at $8.81M, representing 2.66% of its reported portfolio and ranking #3.

Has Future Fund LLC been buying or selling HALO?

In the latest 13F filing (Q3 2026), Future Fund LLC reduced its position in HALO. The position peaked in Q2 2026 at 142.01K shares.

Which other funds hold HALO?

Other major institutional holders of HALO include CONGRESS ASSET MANAGEMENT CO, SNYDER CAPITAL MANAGEMENT L P, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, among 45 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.